Xuqing Zhang

Xuqing Zhang is a Senior Director of Discovery Chemistry at SK Life Science Labs, a position held since October 2023, focusing on utilizing the ubiquitin-protease system for developing transformative medicines. Prior to this, Xuqing Zhang served as Senior Director of Medicinal Chemistry at Proteovant Therapeutics from April 2021 to October 2023, where responsibilities included advancing disease-modifying therapies through novel protein degrader programs. Xuqing Zhang's extensive experience includes 21 years at The Janssen Pharmaceutical Companies of Johnson & Johnson, progressing from Scientist to Senior Principal Scientist. Academic qualifications comprise a PhD in Organic Chemistry from Rensselaer Polytechnic Institute, an MS in Organic Chemistry from the Chinese Academy of Sciences, and a BS in Polymer Science from Fudan University.